investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Discovery of Novel Rare Variants as Ovarian Cancer Susceptibility Factors

Michelle Hildebrandt

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

No posts

Related projects

Simon A Gayther

The Contribution of Rare Alleles to Ovarian Cancer in the Population

Ovary

Pathology

Andre Michael Lieber

Evaluation of Vectors Based on Group B Adenoviruses

Ovary

Pathology

Julia Salzman

Discovering genomic rearrangements under selection in serious ovarian cancer

Ovary

Sandra Orsulic

(PQA3) Why is Ovarian Cancer Primarily a Disease of Postmenopausal Women

Ovary

Tsz-Kwong Man

Harnessing p27 for Prognostication of Pediatric Osteosarcoma

Ovary

Pediatric oncology or childhood cancer

Gary Gilliland

Cancer Center Support grant (comprehensive)

Ovary

Frederick Appelbaum

Cancer Center Support Grant (Comprehensive)

Ovary

Scott H Kaufmann

Mayo Clinic SPORE in Ovarian Cancer

Ovary

Pathology

Kunle O Odunsi

mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity

Ovary

Pathology